Beneficient-A Stock Price, News & Analysis

Beneficient (NASDAQ: BENF) announced that Nasdaq notified the company on October 29, 2025 that it has regained compliance with two listing standards: (i) the Nasdaq periodic reporting requirement after filing its Form 10-K for fiscal year ended March 31, 2025 and Form 10-Q for quarter ended June 30, 2025, and (ii) the $35 million market value of listed securities requirement as an alternative to the minimum stockholders’ equity test.

The company remains noncompliant with the $1.00 per share bid price requirement and must regain compliance within the extension period granted by the Nasdaq Hearings Panel. If compliance is not achieved, the company plans to seek stockholder approval for a reverse stock split intended to restore the $1.00 bid price for the required 10-consecutive trading day period.

Beneficient (NASDAQ: BENF) announced a Limited Conversion where Chairman Thomas O. Hicks and Interim CEO James G. Silk converted approximately $48.0M and $4.6M of Preferred A-1 units of subsidiary BCH into 92,485,639 and 8,808,649 shares of Class A common stock, respectively.

The conversion follows a Nasdaq notice on October 3, 2025 regarding noncompliance with the minimum stockholders’ equity requirement and is intended to support compliance with the MVLS $35M alternative. The Conversion Shares are subject to a voting and lock-up until October 1, 2028, and Messrs. Hicks and Silk agreed to forfeit any appreciation in value of the Conversion Shares at lock-up expiration.

Beneficient (NASDAQ: BENF) reported fiscal 2026 first quarter results for the period ended June 30, 2025, highlighting cost reductions, new primary capital transactions and asset dispositions that strengthened liquidity and reporting compliance.

Key facts: Investments at fair value $263.8M (down from $291.4M); operating expenses $80.0M including a $62.8M loss contingency accrual; operating expenses excluding special items were $17.2M (1% decline YoY); loan portfolio net $230.7M with allowance for credit losses $352.7M; cash $7.6M and total debt $108.4M; asset sales generated $38.1M gross proceeds.

Beneficient (NASDAQ: BENF) reported its Q4 and fiscal year 2025 results, marking significant operational improvements. The company's investments fair value stood at $291.4 million, supporting a net loan portfolio of $244.1 million as of March 31, 2025.

Key highlights include: 91% reduction in operating expenses to $14.3 million in Q4 FY2025, completion of three additional Primary Capital transactions worth $11.8 million, and post-period sale of Customer ExAlt Trust investments for over $36 million. The company appointed Thomas O. Hicks as Chairman and James G. Silk as interim CEO.

Ben's loan portfolio is diversified across 210 private market funds and approximately 710 investments. The company ended the period with $1.3 million in cash and $117.9 million in debt, while receiving $30.4 million in distributions from alternative assets for FY2025.

Beneficient (NASDAQ: BENF) has received a conditional listing extension from the Nasdaq Hearings Panel. The company must meet two key requirements to maintain its listing: file delayed financial reports and demonstrate compliance with the $1.00 per share minimum bid price requirement.

The delayed reports include the Annual Report (Form 10-K) for FY2025 and Q2 2025 Quarterly Report (Form 10-Q). To address the bid price requirement, BENF plans to seek shareholder approval for a reverse stock split if necessary. The company expects to meet these conditions within the granted extension period.

Beneficient (NASDAQ: BENF) has received an additional delisting notice from Nasdaq due to delayed filing of its Q2 2025 Form 10-Q. This follows previous notifications regarding non-compliance with the $1.00 minimum bid price requirement and delayed filing of FY2025 Form 10-K.

The company has requested a hearing before the Nasdaq Hearings Panel to present its compliance plan and seek an extension. While Beneficient is taking steps to address these issues, there is no guarantee the Panel will approve continued listing.

Beneficient (NASDAQ: BENF) announced significant leadership changes with the separation of its Chairman and CEO roles. Thomas O. Hicks, a private equity pioneer who has overseen more than $50 billion in leveraged acquisitions, has been appointed as Chairman of the Board. James G. Silk has been named interim CEO, bringing over 20 years of financial services experience.

Silk previously served as Beneficient's Executive Vice President and Chief Legal Officer from January 2020 to May 2024, while Hicks has been serving on the Board since 2018. The appointments aim to revitalize the company's momentum and enhance shareholder value through their combined expertise in alternative assets and financial services.

Beneficient (NASDAQ: BENF) has received a delisting notice from Nasdaq due to two compliance issues: failure to maintain the minimum $1.00 bid price requirement and delayed filing of its Annual Report on Form 10-K for the fiscal year ended March 31, 2025.

The company plans to request a hearing before the Nasdaq Hearings Panel and seek a stay of any suspension action. During the hearing, Beneficient will present its compliance plan and request an extension. However, there is no guarantee that the Panel will grant the company's request for continued listing.

Beneficient (NASDAQ: BENF) has completed a $1.91 million primary capital transaction with Mendoza Ventures Growth Fund III, LP. The deal represents Ben's third GP Primary transaction of the fiscal year and fourth since launching the program in late 2024.

The Fund received Resettable Convertible Preferred Stock convertible into Ben's Class A common stock. The transaction is expected to increase Ben's ExAlt loan portfolio collateral by $1.91 million. Additionally, Ben entered into a Preferred Liquidity Provider Program Agreement with the Fund to facilitate ongoing liquidity solutions.

This initiative is part of Ben's GP Primary Commitment Program, which aims to address up to $330 billion of potential demand for primary commitments in fundraising.